Literature DB >> 27357378

Neuropsychological Effects of Cerebral Amyloid Angiopathy.

Matthew Schrag1, Howard Kirshner2.   

Abstract

Cerebral amyloid angiopathy is a condition of the cerebral arterioles and to a lesser extent capillaries and veins, wherein beta-amyloid is deposited. In arterioles, this preferentially targets vascular smooth muscle cells and in the later stages undermines the stability of the vessel. This condition is frequently comorbid with Alzheimer's disease and its role in cognitive impairment and dementia is a topic of considerable recent research. This article reviews recent literature which confirms that CAA independently contributes to cognitive impairment by potentiating the neurodegeneration of Alzheimer's disease, by predisposing to microhemorrhagic and microischemic injury to the brain parenchyma, and by interfering with the autoregulation of CNS blood flow. In this review, we discuss the clinical presentation of cerebral amyloid angiopathy, with a focus on the neuropsychological manifestations of this vasculopathy.

Entities:  

Keywords:  Autoregulation; Azheimer’s disease; Cerebral amyloid angiopathy; Cognition; Complement; Microhemorrhages

Mesh:

Year:  2016        PMID: 27357378     DOI: 10.1007/s11910-016-0674-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  42 in total

1.  Focal cortical subarachnoid hemorrhage revealed by recurrent paresthesias: a clinico-radiological syndrome strongly associated with cerebral amyloid angiopathy.

Authors:  Marion Apoil; Julien Cogez; Lydie Dubuc; Mathieu Bataille; Vincent de la Sayette; Emmanuel Touzé; Fausto Viader
Journal:  Cerebrovasc Dis       Date:  2013-09-11       Impact factor: 2.762

2.  Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy.

Authors:  Andrew Dumas; Gregory A Dierksen; M Edip Gurol; Amy Halpin; Sergi Martinez-Ramirez; Kristin Schwab; Jonathan Rosand; Anand Viswanathan; David H Salat; Jonathan R Polimeni; Steven M Greenberg
Journal:  Ann Neurol       Date:  2012-07       Impact factor: 10.422

3.  Microbleeds do not affect rate of cognitive decline in Alzheimer disease.

Authors:  Annelies E van der Vlies; Jeroen D C Goos; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier
Journal:  Neurology       Date:  2012-08-08       Impact factor: 9.910

Review 4.  Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging.

Authors:  Matthew Schrag; David M Greer
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-10-05       Impact factor: 2.136

5.  Iron quantification of microbleeds in postmortem brain.

Authors:  Grant McAuley; Matthew Schrag; Samuel Barnes; Andre Obenaus; April Dickson; Barbara Holshouser; Wolff Kirsch
Journal:  Magn Reson Med       Date:  2010-12-16       Impact factor: 4.668

6.  Course of cerebral amyloid angiopathy-related inflammation.

Authors:  C Kinnecom; M H Lev; L Wendell; E E Smith; J Rosand; M P Frosch; S M Greenberg
Journal:  Neurology       Date:  2007-04-24       Impact factor: 9.910

7.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

Authors:  H V Vinters; J J Gilbert
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

8.  Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

Authors:  M Kawai; R N Kalaria; P Cras; S L Siedlak; M E Velasco; E R Shelton; H W Chan; B D Greenberg; G Perry
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

9.  Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.

Authors:  Patricia A Boyle; Lei Yu; Sukriti Nag; Sue Leurgans; Robert S Wilson; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2015-11-04       Impact factor: 9.910

10.  Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed.

Authors:  Kristen M Kennedy; Naftali Raz
Journal:  Neuropsychologia       Date:  2009-01-08       Impact factor: 3.139

View more
  7 in total

1.  White Matter Disease and Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke.

Authors:  E A Mistry; A M Mistry; T Mehta; N Arora; A K Starosciak; F D L R La Rosa; J E Siegler; S E Kasner; R Chitale; M Fusco; M Froehler; S Yaghi; M Schrag; P Khatri
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-12       Impact factor: 3.825

Review 2.  Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy.

Authors:  Carolyn Akers; Lealani May Y Acosta; Ciaran Considine; Daniel Claassen; Howard Kirshner; Matthew Schrag
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-27       Impact factor: 5.081

Review 3.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

4.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

5.  Rhenium and technetium complexes of thioamide derivatives of pyridylhydrazine that bind to amyloid-β plaques.

Authors:  Scott P Fletcher; Asif Noor; James L Hickey; Catriona A McLean; Jonathan M White; Paul S Donnelly
Journal:  J Biol Inorg Chem       Date:  2018-07-07       Impact factor: 3.358

6.  Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease.

Authors:  Dennis M Kamara; Umesh Gangishetti; Marla Gearing; Monica Willis-Parker; Liping Zhao; William T Hu; Lary C Walker
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Authors:  Jian-Ming Li; Li-Ling Huang; Fei Liu; Bei-Sha Tang; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2017-08-25       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.